Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

NCT00207805 is registered in ClinicalTrials.gov with Centre National de Greffe de Moelle Osseuse as lead sponsor.

NCT NCT00207805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00207805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma
Lead sponsor
Centre National de Greffe de Moelle Osseuse
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2003
Completion date
Not reported
Enrollment
202
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma